Skip to content
The 2025 pharma forecast episode artwork

Jan 23, 2025 20 min

The 2025 pharma forecast

from EMJ GOLD: Pharma news, views and analysis Hosted by EMJ

Curious to discover what might lie ahead for industry in 2025? Join Isabel and Jade in this special episode of the EMJ GOLD podcast as they reflect on whether last year's predictions for 2024 came true, while three special guests share their predictions and hopes for pharma in the year ahead. The line-up includes Jennifer Schranz of Ipsen, Mercedes Diz of Almirall and EMJ's own Dr Jonathan Sackier - all of whom share their predictions in their areas of expertise. A little more on GOLD's guests… Jennifer Schranz is the Senior Vice President, Global Head of Rare Diseases at Ipsen, where she oversees the Rare Diseases therapy area with a focus on R&D strategy and execution. During her time at the business, she has led talented teams of scientists and fostered strong internal collaborations within the company, leveraging her clinical development expertise to advance Ipsen's vision of addressing challenging rare diseases. Mercedes Diz has over 20 years' experience in the pharmaceutical industry, having graduated with a degree in Biochemistry and Molecular Biology from the Autonomous University of Madrid. She has worked in a number of different pharmaceutical companies, from J&J to Pfizer, and is also a keen member of the Healthcare Businesswomen's Association. At Almirall, she leads portfolio strategy and commercial innovation for global brands, new products and digital and cultural transformation. Dr Jonathan Sackier is Chairman at EMJ and the host of the EMJ podcast, where he utilises his experience as a physician to discuss the latest breakthroughs and challenges in the medical field with fellow practitioners and experts. Jonathan is a founding partner of many start-ups in the medical technology space and created the world's first operating room robot.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

The 2025 pharma forecast

0:00 20:15

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of EMJ GOLD: Pharma news, views and analysis?

This episode is 20 minutes long.

When was this EMJ GOLD: Pharma news, views and analysis episode published?

This episode was published on January 23, 2025.

Can I download this EMJ GOLD: Pharma news, views and analysis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.